Vismodegib for Treatment of Basal Cell Carcinoma (Erivedge)

Clinical Trial ID NCT01543581

PubWeight™ 5.71‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01543581

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015 2.02
2 Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. Biologics 2015 0.85
3 Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. Dermatol Ther (Heidelb) 2013 0.76
4 Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face. Case Rep Oncol Med 2015 0.75
5 Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma. J Exp Pharmacol 2012 0.75
6 Investigational agents in metastatic basal cell carcinoma: focus on vismodegib. J Exp Pharmacol 2012 0.75
Next 100